Sugi Predict

Sugi Predict / Compounds / SCHEMBL1829344

SCHEMBL1829344

SCHEMBL1829344

Clc1ccc(-c2cc[nH]n2)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 3/20 0.50
▸ HPGD P15428 2/20 0.45
▸ HAO1 Q9UJM8 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ KMO O15229 8/20 0.44
▸ CYP1B1 Q16678 1/20 0.43
▸ NOTUM Q6P988 2/20 0.43
▸ IDO1 P14902 1/20 0.42
▸ IKBKB O14920 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230212 0.85 KMO (0.57) AHRHPGDHAO1LMNAKMO
SCHEMBL6787087 0.83 ALDH1A1 (0.46) HPGDKMOIKBKBALDH1A1MAPT
SCHEMBL16627909 0.83 ESR2 (0.47) —
SCHEMBL12096316 0.80 KMO (0.49) HPGDLMNAKMOALDH1A1MAPT
SCHEMBL8195799 0.80 KMO (0.49) HPGDLMNAKMO
SCHEMBL22873416 0.79 HAO1 (0.31) HPGDHAO1LMNAKMONOTUM
SCHEMBL1810795 0.79 CYP11B2 (0.48) HPGDLMNAKMOALDH1A1
SCHEMBL15012113 0.79 NOTUM (0.61) NOTUMIDO1
SCHEMBL13672579 0.79 NOTUM (0.43) HPGDHAO1LMNANOTUM
SCHEMBL1758759 0.79 PNMT (0.36) HPGDHAO1LMNAKMONOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634391-B2 Compounds which are inhibitors of Notum UCL BUSINESS LTD (GB) 2023-04-25 — — US disclosed
EP-3885340-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORPORATION (FI) 2021-09-29 — — EP disclosed
US-11046713-B2 Androgen receptor modulating compounds ORION CORPORATION (FI) 2021-06-29 — — US disclosed
US-20210171475-A1 COMPOUNDS UCL BUSINESS LTD (GB) 2021-06-10 — — US disclosed
EP-3369732-B1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2021-05-26 — — EP disclosed
US-20200299307-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2020-09-24 — — US disclosed
US-10711013-B2 Androgen receptor modulating compounds ORION CORPORATION (FI) 2020-07-14 — — US disclosed
US-20190100536-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2019-04-04 — — US disclosed
US-10118933-B2 Androgen receptor modulating compounds ORION CORPORATION (FI) 2018-11-06 — — US disclosed
EP-3369732-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORPORATION (FI) 2018-09-05 — — EP disclosed
US-20070004738-A1 Substituted pyrazoles ORTHO MCNEIL PHARMACEUTICAL, INC. 2007-01-04 — — US disclosed
EP-1315491-B1 USE OF SUBSTITUTED PYRAZOLES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF ALLERGIES ORTHO MCNEIL PHARM INC (US) 2006-08-09 — — EP disclosed
CN-1468239-A Substituted pyrazoles ����-������ҩƷ��˾ 2004-01-14 — — CN disclosed
EP-1315491-A2 METHOD FOR TREATING ALLERGIES USING SUBSTITUTED PYRAZOLES Ortho-McNeil Pharmaceutical, Inc. (US) 2003-06-04 — — EP disclosed
EP-1309591-A2 SUBSTITUTED PYRAZOLES Ortho-McNeil Pharmaceutical, Inc. (US) 2003-05-14 — — EP disclosed
US-20030073672-A1 Method for treating allergies using substituted pyrazoles ORTHO MCNEIL PHARMACEUTICAL, INC. 2003-04-17 — — US disclosed
US-20030069240-A1 Method for treating allergies using substituted pyrazoles JANSSEN PHARMACEUTICA N.V. (BE) 2003-04-10 — — US disclosed
US-20020040020-A1 Substituted pyrazoles ORTHO MCNEIL PHARMACEUTICAL, INC. 2002-04-04 — — US disclosed
WO-2002020012-A2 METHOD FOR TREATING ALLERGIES USING SUBSTITUTED PYRAZOLES ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2002-03-14 — — WO disclosed
WO-2002014314-A2 SUBSTITUTED PYRAZOLES ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2002-02-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10118933-B2 Androgen receptor modulating compounds AR, NR5A1, SHBG AHR 422/4885HPGD 704/4885HAO1 4192/4885
US-11634391-B2 Compounds which are inhibitors of Notum NOTUM, GOT2, GOT1 AHR 4606/4885HPGD 632/4885HAO1 2387/4885
US-20070004738-A1 Substituted pyrazoles CTSS, CTSZ, CTSB AHR 1389/4885HPGD 2193/4885HAO1 2184/4885
US-20030069240-A1 Method for treating allergies using substituted pyrazoles TSLP, IL33, HRH2 AHR 23/4885HPGD 675/4885HAO1 1487/4885
US-20210171475-A1 COMPOUNDS GOT2, GOT1, OAT AHR 4068/4885HPGD 1075/4885HAO1 3679/4885
US-20030073672-A1 Method for treating allergies using substituted pyrazoles TSLP, IL33, HRH2 AHR 23/4885HPGD 675/4885HAO1 1487/4885
US-10711013-B2 Androgen receptor modulating compounds AR, NR5A1, SHBG AHR 422/4885HPGD 704/4885HAO1 4192/4885
US-20200299307-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS AR, NR5A1, SHBG AHR 422/4885HPGD 704/4885HAO1 4192/4885
US-20190100536-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS AR, NR5A1, SHBG AHR 422/4885HPGD 704/4885HAO1 4192/4885
US-11046713-B2 Androgen receptor modulating compounds AR, NR5A1, SHBG AHR 422/4885HPGD 704/4885HAO1 4192/4885
US-20020040020-A1 Substituted pyrazoles CTSS, CTSZ, CTSV AHR 1663/4885HPGD 1976/4885HAO1 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.